The end of cancer? These 29 emerging AI stocks are developing tech that will allow early identification of life changing diseases like cancer and Alzheimer's.
To own NexGen today, you really have to believe that Rook I will move from a permitted concept to a built and producing uranium asset, despite the company having no revenue, ongoing losses of about CA$333.2m and repeated shareholder dilution. The recent share price jump around the Canadian Nuclear Safety Commission timetable underlines how central those 2026 licensing hearings, and the nearer‑term January 9 intervention deadline, have become for the short term story: regulatory momentum is now the key catalyst, more so than exploration success or index inclusion. At the same time, the move highlights the risks that have not gone away, including valuation already rich on book value, continued unprofitability and the possibility that any delay or adverse feedback in the CNSC process could quickly sour sentiment.
However, one regulatory setback around Rook I could rapidly change how all of this looks for investors. NexGen Energy's shares have been on the rise but are still potentially undervalued. Find out how large the opportunity might be.Explore 7 other fair value estimates on NexGen Energy - why the stock might be worth over 4x more than the current price!
Disagree with this assessment? Create your own narrative in under 3 minutes - extraordinary investment returns rarely come from following the herd.
Don't miss your shot at the next 10-bagger. Our latest stock picks just dropped:
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com